You are here

  • Home
  • Archive
  • Volume 31, Issue Suppl 3
  • 918 Correlative analyses of phase 1b study of navicixizumab plus paclitaxel in patients with platinum resistant ovarian cancer using xerna™ TME panel

Alerts

Article menu

Download PDFPDF

Ovarian cancer
918 Correlative analyses of phase 1b study of navicixizumab plus paclitaxel in patients with platinum resistant ovarian cancer using xerna™ TME panel
Free
You need to be signed in to access email alerts. If you have an account log in with your user name and password. If you don't have an account you can just enter your email address in the email box below.
Sign In to Email Alerts with your Email Address